Cathie Wood’s ARK Invest Buys Over 8 Million Shares of Ginkgo Bioworks
A couple of Cathie Wood's ARK Invest exchange-traded funds bought over 8 million shares of Ginkgo Bioworks on October 6.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these funds bought roughly $87 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these funds were very mixed on Wednesday. Note though that they are up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 1,525,065 shares of Ginkgo, and ARK Innovation ETF (NYSEARCA: ARKK) bought 6,739,168 shares. At Wednesday’s closing prices, this would have valued the sales at roughly $87.5 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is up less than 8% and the other is up 17% in the past year.
Check out all the ARK Invest purchases for Wednesday as well:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | TDOC | TELADOC HEALTH | 41,819 |
| ARKG | SURF | SURFACE ONCOLOGY | 179,161 |
| ARKG | QSI | QUANTUM-SI | 120,419 |
| ARKG | SLGC | SOMALOGIC | 303,876 |
| ARKG | DYNS | DYNAMICS SPECIAL PURPOSE | 600 |
| ARKG | DNA | GINKGO BIOWORKS | 1,525,065 |
| ARKG | BEAM | BEAM THERAPEUTICS | 75,862 |
| ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 103,497 |
| ARKK | TWOU | 2U | 42,060 |
| ARKK | SSYS | STRATASYS | 77,800 |
| ARKK | SGFY | SIGNIFY HEALTH | 325,861 |
| ARKK | PATH | UIPATH | 580,632 |
| ARKK | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA | 57,511 |
| ARKK | BEAM | BEAM THERAPEUTICS | 17,763 |
| ARKK | DNA | GINKGO BIOWORKS | 6,739,168 |
| ARKQ | ACHR | ARCHER AVIATION | 58,153 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 148,623 |
| ARKQ | VLD | VELO3D | 106,782 |
| ARKQ | MKFG | MARKFORGED | 81,700 |
| ARKQ | NIU | NIU TECHNOLOGIES | 15,528 |
| ARKW | SQ | SQUARE | 13,256 |
| ARKW | TDOC | TELADOC HEALTH | 31,367 |
| ARKW | VUZI | VUZIX | 103,245 |
| ARKX | PRNT | 3D PRINTING ETF | 1,022 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
